{"art_url":"https://d1liwsgvdtvkdb.cloudfront.net/art/q_6a90a613793a10e8d5/qm-ascii-fit-v1/0bda9e24344607c7a35cdeaf4dcbb14a3819315eb1979114aea77f1c88642c1f/1200.jpg","art_url_600":"https://d1liwsgvdtvkdb.cloudfront.net/art/q_6a90a613793a10e8d5/qm-ascii-fit-v1/0bda9e24344607c7a35cdeaf4dcbb14a3819315eb1979114aea77f1c88642c1f/600.jpg","id":"q_6a90a613793a10e8d5","text":"Do GLP-1 receptor agonists reduce cardiovascular events in adults with obesity but without diabetes, and how does the effect vary by baseline cardiovascular disease?","display_title":"Do GLP-1 receptor agonists reduce cardiovascular events in adults with obesity?","slug":"do-glp-1-receptor-agonists-reduce-cardiovascular-events-in","status":"answered","entities":["GLP1","OBESITY","CARDIOVASCULAR"],"ref_url":null,"forecasters":null,"created":"2026-08-27T21:03:15.67211Z","budget_cents":100,"tier":"standard","raised_cents":100,"funders":1,"artifact":{"id":"a_6a90a7058e62253dd1","question_id":"q_6a90a613793a10e8d5","latest_rev":1,"machine_price_cents":50,"freshness_hours":72,"external_url":null,"teaser":{"summary":"Yes, semaglutide reduced major cardiovascular events by 20% in adults with obesity, established cardiovascular disease, and no diabetes; evidence does not establish a benefit without established disease, while benefits were generally consistent across SELECT subgroups.","verdict":"Interpreting your question as: \"Do GLP-1 receptor agonists reduce cardiovascular events in adults with obesity but without diabetes, and how does the effect vary by baseline cardiovascular disease?\"","citations":6},"downloads":0,"unique_buyers":0,"age_hours":2021.8}}
